About GenScript
GenScript Biotech Corporation (Stock Code: 1548.HK) is a global biotechnology group. Founded in 2002, GenScript has an established global presence across North America, Europe, the Greater China, and Asia Pacific. GenScript's businesses encompass four major categories based on its leading gene synthesis technology, including operation as a Life Science CRO, enzyme and synthetic biology products, biologics development and manufacturing, and cell therapy.
GenScript is committed to striving towards its vision of being the most reliable biotech company in the world to make humans and nature healthier through biotechnology
About ProBio
ProBio proactively provides end-to-end CDMO service from drug discovery to commercialization with proactive strategies, professional solutions and efficient processes in cell and gene therapy (CGT), vaccine, biologics discovery and antibody protein drug to accelerate drug development for customers. ProBio’s total cell and gene therapy solution covers CMC of plasmid and virus for IND filing as well as clinical manufacturing and commercial manufacturing. In terms of plasmid service, ProBio supports the most clinical approvals for CGT drugs including mRNA vaccines, CAR-T in China. It is also the first GMP manufacturing platform to provide in vitro transcription (IVT) template linearized plasmids for mRNA vaccines and has supported several mRNA vaccine global enterprises to obtain clinical approvals. In terms of viral vector service, \ProBio has a stable and high-yield viral vector platform.
Job Scope:
We are seeking a highly motivated business development professional to join our dynamic, fast growing European BD team. This is a great opportunity to build and expand your experiences because you will be navigating through both biologics and GCT space!
Location: BENELUX or France is preferred (remote or hybrid)
Key Responsibilities:
- Develop the business development strategy and oversee the effective execution, to achieve the financial goal in several EU countries/regions.
- Build country-specific strategies for regional market penetration and funnel of opportunities and deliver on revenue plans.
- Work closely with internal teams to promote, and evaluate customer business needs and serve as the main contact for business acquisition.
- Proactively prospecting potential customers for the whole CDMO service lines and building long-term relationships with customers.
- Provide accurate CRM input regarding sales activities, forecast, and lost reporting as well as competitive information.
- Lead in the opportunity assessment, financial justification, due diligence, transaction design, contract negotiation, and completion of the deals, including but not limited to a strategic partnership, and co-development.
- Take the lead in strategic accounts management and strategic deal-making.
- Build and maintain a professional network with external companies and KOLs in the biopharma industry.
- Up to 50% of business travel is required for a customer visit
Requirements:
- University degree in life sciences discipline, PhD Degree as a plus.
- Fluent and professional English level, with an additional European language as a plus.
- At least 5 years’ experience of leading business development or commercial support, sales, project management, marketing and related functions in pharmaceutical or CRO/CDMO with a proven track record of achieving sales goals and closing large deals.
- Thorough understanding of the biopharmaceutical industry and motivated in learning new service solutions and/or new technologies.
- Exceptional awareness of the biopharmaceutical ecosystem and deal-making landscape.
- Team player with a can-do mindset
- Ability to work in a fast-paced and challenging environment with the ability to handle multiple projects simultaneously and meet deadlines.
#LI-AH1
#PB
GenScript USA Inc/ProBio Inc. is a proud equal opportunity/affirmative action employer committed to attracting, retaining, and maximizing the performance of a diverse and inclusive workforce. It is the Company's policy to ensure equal employment opportunity without discrimination or harassment based on race, color, religion, sex (including pregnancy, childbirth, or related medical conditions), sexual orientation, gender identity or expression, age, disability, national origin, marital or domestic/civil partnership status, genetic information, citizenship status, uniformed service member or veteran status, or any other characteristic protected by law.
GenScript USA Inc./ProBio Inc. maintains a drug-free workplace.
What We Do
Founded in 2002 and listed on the Hong Kong Stock Exchange in 2015, GenScript has an established global presence across Greater China, North America, the EU, and Asia Pacific. Today, over 300,000 customers from over 160 countries and regions worldwide have used GenScript’s premier, convenient, and reliable products and services. GenScript currently has over 5,000 employees globally, 33% holding master’s and/or Ph.D. degrees. In addition, GenScript has a number of leading commercial technologies developed in the fields of synthetic biology, immunotherapy, antibody design, chemical synthesis, and bioinformatics, including more than 100 patents and over 270 patent applications. As of June 2022, GenScript's products and services have been cited by 74,700 scientific papers worldwide. GenScript is committed to striving toward its vision of being the most reliable biotech company in the world to make humans and nature healthier through biotechnology.
